We provide end-to-end solutions for commercial and research customers seeking quality and flexibility in nucleic acid technology.
Oligonucleotide Modification
Our enzymatic platform offers scalable, site-specific labeling for probes, barcodes, and antibody conjugates with high efficiency and minimal sequence bias.
Using our proprietary DNA Linker platform, we deliver customizable AOC development for next-gen antibody–drug conjugates and targeted delivery systems.